Biotech

All Articles

BMS axes bispecific months after submitting to operate phase 3 test

.Bristol Myers Squibb has had a whiplash change of heart on its own BCMA bispecific T-cell engager, ...

Charles Baum takes over Terremoto as CEO

.Charles Baum, M.D., Ph.D., who oversaw Mirati Therapies' $ 5.8 billion purchase to Bristol Myers Sq...

Asarina to shut after efforts to partner Tourette's drug neglect

.After reaching out to much more than 200 providers to companion a Tourette disorder treatment that ...

Novartis pens $150M ahead of time bispecifics handle Dren Bio

.Novartis has actually had some bad luck with bispecific antitoxins in the past, however determining...

AstraZeneca plants an EGFR plant with Pinetree package worth $45M

.Pinetree Rehabs will certainly assist AstraZeneca plant some trees in its own pipeline with a new p...

GRO rounds up $60M set B to take gout pain treatment into facility

.GRO Biosciences has finished the week along with an added $60.3 thousand in the bank, which the hea...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava drops chief executive officer

.Welcome to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings an...